Building an Evidence Workflow: AI-Assisted Literature Review That Survives Scrutiny

Literature reviews in biopharma and biotech are rarely passive exercises. Whether supporting a target validation memo, preparing a regulatory submission file, or mapping a competitive landscape, an evidence synthesis must survive rigorous internal and external review. Large language models (LLMs) and retrieval-augmented generation (RAG) architectures offer compelling speed advantages for literature screening, but adopting them without structural guardrails introduces unacceptable risks to data integrity.

Building a review workflow that survives scrutiny requires moving past informal chat interfaces and ad hoc prompting. Teams need structured pipelines where search strategies remain deterministic, language models operate under tight constraints, and every extracted claim links back to a verifiable source fragment.

Designing Search Strategies for Algorithmic Ingestion

A resilient review process begins long before an LLM parses a single abstract. Teams often make the mistake of replacing structured database queries with loose, natural language prompts inside an AI interface. This approach destroys the deterministic foundation required for reproducible literature synthesis.

Algorithmic workflows should consume query outputs generated from established search syntax across databases such as PubMed, Embase, or IEEE Xplore. Traditional Boolean strings, explicit MeSH terms, and controlled vocabularies ensure that the initial candidate pool is comprehensive and documented. Semantic search and vector embeddings can supplement this initial pool by capturing conceptually relevant papers that lack specific keywords, but they should operate as an additive layer rather than a primary filter.

To maintain reproducibility, search strategies must be captured as fixed artifacts. Documenting exact search strings, database platform versions, filter settings, and retrieval timestamps allows subsequent teams or external auditors to reconstruct the raw corpus precisely before any AI processing occurs.

Tiered Screening and the Mechanics of LLM Assistance

Once a deterministic candidate pool is established, language models excel at preliminary title and abstract triage. However, using open-ended queries like "Is this paper relevant to oncology targets?" invites high variance and subjective interpretation.

Instead, LLMs perform best when configured as schema-driven classifiers. The screening protocol should define explicit inclusion and exclusion criteria transformed into a structured output format, such as JSON. By constraining the model to evaluate specific variables independently, teams can isolate the exact rationale for a paper's inclusion or rejection.

• Define binary decision criteria (e.g., subject species, study type, specific assay format) rather than holistic scoring scales.
• Require the model to extract verbatim quote snippets from the text to justify each pass/fail decision.
• Set the generation temperature to zero or use deterministic sampling settings supported by the underlying API.
• Process citations in isolated batches with consistent system instructions to prevent context drift across the library.

Managing Hallucination Risk Where It Hurts Most

The narrative surrounding LLM hallucination often focuses on completely fabricated facts or invented references. While these errors are easy to catch using automated checks, the far more dangerous failure mode in life sciences is the plausible misinterpretation of complex technical detail.

Hallucination risk bites hardest during quantitative data extraction and comparative analysis. An LLM may accurately summarize a paper's conclusion while completely misstating an IC50 value, swapping a confidence interval, or confusing an in vitro model with an in vivo study. Similarly, models frequently struggle with nuanced negative controls or conditional conclusions, transforming a cautious experimental finding into an absolute assertion.

Mitigating these subtle errors requires deterministic verification loops. Extraction workflows should employ retrieval methods that force the model to map every extracted data point directly to a character-offset citation within the source document. If an extracted numeric value cannot be located verbatim or within a tight logical transform of the source text, the entry must be flagged for mandatory human review.

Dual Review, Provenance, and the Human Gatekeeper

No current algorithmic pipeline eliminates the need for human oversight. Rather than replacing human reviewers, AI workflows are best deployed to establish an efficient dual-review framework where model output serves as a primary screener or independent second reader.

Provenance capture is the operational backbone of a defensible workflow. Every entry in the final evidence matrix should maintain a complete audit lineage. This includes the raw source PDF, text extraction logs, prompt template, model version identifier, raw API response, and the signature of the human subject matter expert who verified the record.

It is vital for teams to recognize that while software tools and AI platforms may support evidence collection and review workflows, they do not satisfy regulatory compliance or formal GxP validation requirements on their own. Ultimate responsibility for data integrity rests with the organization's quality management system, standard operating procedures, and designated human experts. Teams evaluating commercial or open-source literature tools should review their specific vendor agreements and data privacy terms directly to verify how input data and proprietary literature collections are handled.

Citation Integrity and Audit-Ready Archiving

The final phase of an evidence workflow is post-processing and archival verification. Before any literature synthesis is finalized for decision-making, the generated references must undergo automated metadata reconciliation.

Direct integration with public registries via APIs allows workflows to validate Digital Object Identifiers (DOIs), verify publication metadata, and flag retracted or corrected literature. An automated check for retracted papers protects internal strategy from building upon discredited data.

Finally, true reproducibility demands that the entire operational state of the review be archived. Storing frozen dependencies, prompt templates, retrieved source files, and audit logs creates a permanent record of how decisions were made. When internal review boards evaluate an evidence synthesis months or years later, a fully documented, provenance-tracked pipeline ensures the organization can defend every step of its synthesis.

How it works in practice

• What data goes in. Bibliographic records and abstracts exported from the databases searched, full-text PDFs for anything that passes title-and-abstract screening, and the review's own inclusion and exclusion criteria written out precisely enough for a model to apply them.
• What the model predicts or ranks. For each record, how likely it is to meet the inclusion criteria — used to order the screening queue and, at the extraction stage, to pull specified fields such as population, intervention, comparator, outcome and effect size from full text.
• Technique or model family. Embedding-based relevance ranking or a fine-tuned classifier for screening; a large language model in a retrieval-augmented, quote-first configuration for extraction, so every extracted value carries the sentence it came from.
• How it is trained or validated. Calibrated on a human-screened seed set, with recall measured against dual human screening on a sample. Thresholds are set for near-total recall; a false exclusion silently biases the review, while a false inclusion merely costs a few minutes.
• What the team does with the output. Reviewers screen a ranked queue and check extracted fields against the quoted source rather than transcribing them, while dual review, disagreement resolution and the PRISMA record stay entirely human.
• A representative example (illustrative, not a measured result). Input: 4,200 deduplicated abstracts plus the stated criteria. Output: a ranked queue in which the model's top 800 records contain every study a human dual-screen also included, with each extracted outcome value linked to its sentence in the source PDF. Numbers like these come from each team's own validation runs, not from the workflow design itself.

Sources

1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews — Page et al., BMJ, 2021.
2. PubMed — U.S. National Library of Medicine.
3. The FAIR Guiding Principles for scientific data management and stewardship — Wilkinson et al., Scientific Data, 2016.